fbpx

Enrolling Studies

Below is the list of studies which are currently open for enrollment to those who qualify.

Study Name Indication Description Location Stipend Apply
Abbvie M16-852Giant Cell ArteritisA Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell ArteritisVandalia, Ohio$1900Apply
PA0011Psoriatic ArthritisA MULTICENTER, PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF BIMEKIZUMAB IN THE TREATMENT OF SUBJECTS WITH ACTIVE PSORIATIC ARTHRITISVandalia, Ohio$440Apply
CA41705Lupus NephritisA PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF OBINUTUZUMAB IN PATIENTS WITH ISN/RPS 2003 CLASS III OR IV LUPUS NEPHRITISVandalia, Ohio$1892Apply
ACTIV-2COVID-19Adaptive Platform Treatment Trial for Outpatients with COVID-19 (Adapt Out COVID)Springboro, Ohio$730Apply
PSA-013Psoriatic ArthritisEfficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.Springboro, Ohio$500Apply

Upcoming Studies

Here is a list of the studies which we are not currently enrolling but expect to begin soon...

We currently do not have an upcoming studies to report.

How long do studies typically remain open for enrollment?

Studies typically have an enrollment period of about 6-months to a year. Of course, some studies enrollment windows are much shorter or longer depending on the enrollment criteria.

How many patients get enrolled on a study?

Most studies we conduct are multi-center studies, meaning there are many sites enrolling the same study across the country or globally. At STAT Research, we typically have enrollment numbers between 1 to 10 per study.

RAPID COVID-19 Testing
$19
Antibody Testing Just $29

BOOK ONLINE NOW
close-link
COVID-19 Testing Info